» Articles » PMID: 18725110

The Linear-quadratic Model is Inappropriate to Model High Dose Per Fraction Effects in Radiosurgery

Overview
Specialties Oncology
Radiology
Date 2008 Aug 30
PMID 18725110
Citations 153
Authors
Affiliations
Soon will be listed here.
Abstract

The linear-quadratic (LQ) model is widely used to model the effect of total dose and dose per fraction in conventionally fractionated radiotherapy. Much of the data used to generate the model are obtained in vitro at doses well below those used in radiosurgery. Clinically, the LQ model often underestimates tumor control observed at radiosurgical doses. The underlying mechanisms implied by the LQ model do not reflect the vascular and stromal damage produced at the high doses per fraction encountered in radiosurgery and ignore the impact of radioresistant subpopulations of cells. The appropriate modeling of both tumor control and normal tissue toxicity in radiosurgery requires the application of emerging understanding of molecular-, cellular-, and tissue-level effects of high-dose/fraction-ionizing radiation and the role of cancer stem cells.

Citing Articles

Single- versus multi-fraction spine stereotactic radiosurgery (ALL-STAR) for patients with spinal metastases: a randomized phase III trial protocol.

Pratapneni A, Klebaner D, Soltys S, Rahimy E, Gibbs I, Chang S BMC Cancer. 2025; 25(1):323.

PMID: 39984889 PMC: 11846292. DOI: 10.1186/s12885-025-13655-6.


Non-melanoma skin cancer treated with hypofractionated 192-Ir contact brachitherapy: a single institution series.

Ciurlia E, Santo B, Barba M, Cavalera E, De Franco P, De Matteis S Front Oncol. 2025; 14:1525926.

PMID: 39896186 PMC: 11782232. DOI: 10.3389/fonc.2024.1525926.


Replacing 2 Gy Per Fraction Equivalent Dose with Fractionation-Specific Biological Equivalent Dose for Normal Tissues.

Luo W, Clair W Int J Mol Sci. 2024; 25(23).

PMID: 39684602 PMC: 11641765. DOI: 10.3390/ijms252312891.


Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 3. Genitourinary and gynecological cancers.

Yoo G, Sung S, Song J, Kim B, Kwak Y, Kim K Radiat Oncol J. 2024; 42(3):171-180.

PMID: 39354820 PMC: 11467485. DOI: 10.3857/roj.2023.01046.


The Effects of Gynecological Tumor Irradiation on the Immune System.

Romero Fernandez J, Cordoba Largo S, Benlloch Rodriguez R, Gil Haro B Cancers (Basel). 2024; 16(16).

PMID: 39199577 PMC: 11352652. DOI: 10.3390/cancers16162804.